Moody Lynn & Lieberson’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.3M | Sell |
105,534
-13,725
| -12% | -$1.81M | 0.7% | 37 |
|
|
2026
Q1 | $16.6M | Buy |
119,259
+21,957
| +23% | +$3.07M | 0.93% | 31 |
|
|
2025
Q4 | $11.9M | Buy |
97,302
+30,750
| +46% | +$3.74M | 0.63% | 37 |
|
|
2025
Q3 | $7.39M | Buy |
66,552
+604
| +0.9% | +$68.7K | 0.4% | 46 |
|
|
2025
Q2 | $7.31M | Sell |
65,948
-1,459
| -2% | -$155K | 0.42% | 44 |
|
|
2025
Q1 | $7.55M | Buy |
67,407
+46,100
| +216% | +$4.76M | 0.48% | 42 |
|
|
2024
Q4 | $1.97M | Buy |
21,307
+16,397
| +334% | +$1.48M | 0.12% | 84 |
|
|
2024
Q3 | $412K | Buy |
4,910
+27
| +0.6% | +$2.06K | 0.03% | 192 |
|
|
2024
Q2 | $335K | Hold |
4,883
| – | – | 0.02% | 191 |
|
|
2024
Q1 | $358K | Sell |
4,883
-173
| -3% | -$13.3K | 0.02% | 187 |
|
|
2023
Q4 | $410K | Hold |
5,056
| – | – | 0.03% | 174 |
|
|
2023
Q3 | $379K | Buy |
5,056
+165
| +3% | +$12.7K | 0.03% | 161 |
|
|
2023
Q2 | $377K | Sell |
4,891
-47,180
| -91% | -$3.76M | 0.03% | 173 |
|
|
2023
Q1 | $4.32M | Sell |
52,071
-1,215
| -2% | -$101K | 0.39% | 52 |
|
|
2022
Q4 | $4.57M | Buy |
53,286
+48,395
| +989% | +$3.83M | 0.42% | 54 |
|
|
2022
Q3 | $302K | Hold |
4,891
| – | – | 0.03% | 188 |
|
|
2022
Q2 | $302K | Hold |
4,891
| – | – | 0.03% | 190 |
|
|
2022
Q1 | $291K | Hold |
4,891
| – | – | 0.02% | 196 |
|
|
2021
Q4 | $355K | Buy |
4,891
+2,000
| +69% | +$138K | 0.02% | 192 |
|
|
2021
Q3 | $202K | Buy |
+2,891
| New | +$203K | 0.02% | 218 |
|
|
2020
Q3 | – | Sell |
-2,928
| Closed | -$225K | – | 200 |
|
|
2020
Q2 | $225K | Hold |
2,928
| – | – | 0.02% | 174 |
|
|
2020
Q1 | $219 | Sell |
2,928
-1,112
| -28% | -$76.8K | 0.03% | 152 |
|
|
2019
Q4 | $263K | Buy |
+4,040
| New | +$263K | 0.03% | 193 |
|
|
2016
Q1 | – | Sell |
-3,603
| Closed | -$365K | – | 172 |
|
|
2015
Q4 | $365K | Sell |
3,603
-28,112
| -89% | -$2.93M | 0.06% | 145 |
|
|
2015
Q3 | $3.11M | Sell |
31,715
-29,365
| -48% | -$3.26M | 0.6% | 54 |
|
|
2015
Q2 | $7.15M | Buy |
61,080
+2,916
| +5% | +$319K | 1.14% | 28 |
|
|
2015
Q1 | $5.71M | Buy |
58,164
+11,365
| +24% | +$1.15M | 0.91% | 42 |
|
|
2014
Q4 | $4.41M | Sell |
46,799
-34,090
| -42% | -$3.53M | 0.63% | 58 |
|
|
2014
Q3 | $8.61M | Buy |
80,889
+77,742
| +2,470% | +$7.61M | 1.28% | 25 |
|
|
2014
Q2 | $261K | Sell |
3,147
-108,682
| -97% | -$8.46M | 0.04% | 173 |
|
|
2014
Q1 | $7.92M | Sell |
111,829
-24,958
| -18% | -$1.96M | 1.15% | 29 |
|
|
2013
Q4 | $10.3M | Sell |
136,787
-2,547
| -2% | -$177K | 1.4% | 20 |
|
|
2013
Q3 | $8.76M | Buy |
139,334
+17,299
| +14% | +$1.03M | 1.35% | 24 |
|
|
2013
Q2 | $6.26M | Buy |
+122,035
| New | +$6.36M | 1.09% | 36 |
|
Other funds holding GILD
LMFP
CIM
ATO
CGH
Moody Lynn & Lieberson's GILD Position: Q2 2026 in Review
Moody Lynn & Lieberson reduced its Gilead Sciences (GILD) stake by 12% in Q2 2026, selling an estimated $1.81M and leaving 105,534 shares worth $13.3M. The position accounts for 0.7% of the portfolio, ranked #37.
Moody Lynn & Lieberson first reported a position in GILD in Q2 2013 and has held it in 34 quarters since. The position peaked at $16.6M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Moody Lynn & Lieberson held 105,534 shares of Gilead Sciences worth $13.3M as of Q2 2026.
- Moody Lynn & Lieberson sold 13,725 Gilead Sciences shares in Q2 2026, an estimated $1.81M.
- Gilead Sciences made up 0.7% of Moody Lynn & Lieberson's portfolio in Q2 2026, its #37 holding.
- Moody Lynn & Lieberson first reported a position in Gilead Sciences in Q2 2013 and has held it in 34 quarters since.
- Moody Lynn & Lieberson's Gilead Sciences position peaked at $16.6M in Q1 2026.
- 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Moody Lynn & Lieberson's 13F filing for Q2 2026, filed 20 Jul 2026.